Martin F. Fey

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Pierre Fenaux, Claude Chastang, Sylvie Chevret et al. · Blood · 1999 · 743 citations

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

Jan J. Cornelissen, Wim L.J. van Putten, Leo F. Verdonck et al. · Blood · 2007 · 470 citations · Full text

Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

Bernhard C. Pestalozzi, David Zahrieh, Karen N. Price et al. · Annals of Oncology · 2006 · 409 citations · Full text

Neuro-oncology, Breast Oncology, Cancer Risk +11

Effect of Priming with Granulocyte Colony-Stimulating Factor on the Outcome of Chemotherapy for Acute Myeloid Leukemia

Bob Löwenberg, Wim van Putten, Matthias Theobald et al. · New England Journal of Medicine · 2003 · 384 citations · Full text